BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 571691)

  • 21. [Treatment of hyperprolactinemic conditions with bromoergocryptine].
    Sas M; Godó G; Morvay J
    Zentralbl Gynakol; 1978; 100(22):1501-7. PubMed ID: 570784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of cyclic gonadotropin secretion by endogenous human prolactin.
    Tyson JE; Khojandi M; Huth J; Smith B; Thomas P
    Am J Obstet Gynecol; 1975 Feb; 121(3):375-9. PubMed ID: 1115151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Remote results of treatment of galactorrhea-amenorrhea syndromes and functional sterility with increased prolactin concentration by means of bromocriptine (Parlodel-Sandoz)].
    Tomala J; Dudkiewicz J; Blecharz AJ
    Ginekol Pol; 1980 Mar; 51(3):255-8. PubMed ID: 6771191
    [No Abstract]   [Full Text] [Related]  

  • 24. Bromocriptine mesylate (Parlodel) in the management of amenorrhea/galactorrhea associated with hyperprolactinemia.
    Cuellar FG
    Obstet Gynecol; 1980 Mar; 55(3):278-84. PubMed ID: 6987580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Restoration of ovarian function by low nocturnal single daily doses of bromocriptine in patients with the galactorrhea-amenorrhea syndrome.
    de Bernal M; de Villamizar M
    Fertil Steril; 1982 Mar; 37(3):392-6. PubMed ID: 6800849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical response of patients with galactorrhea to pergolide, a potent, long-acting dopaminergic ergot derivative.
    Callaghan JT; Cleary RE; Crabtree R; Lemberger L
    Life Sci; 1981 Jan; 28(1):95-102. PubMed ID: 7194408
    [No Abstract]   [Full Text] [Related]  

  • 27. Ovarian refractoriness to gonadotropins in cases of inappropriate lactation: restoration of ovarian function with bromocryptine.
    Mroueh AM; Siler-Khodr TM
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1398-401. PubMed ID: 1036743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [13 trisomy born to a mother with galactorrhea-amenorrhea syndrome].
    Imai T; Kamikubo K; Yasuda K; Miura K
    Nihon Naika Gakkai Zasshi; 1987 Nov; 76(11):1714-8. PubMed ID: 3509172
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapeutic use of bromocriptine in women with amenorrhea-galactorrhea and suspected pituitary microadenoma.
    Jewelewicz R
    Adv Biochem Psychopharmacol; 1980; 23():209-15. PubMed ID: 7395612
    [No Abstract]   [Full Text] [Related]  

  • 30. Pyridoxine treatment of galactorrhoea-amenorrhoea syndromes.
    Lehtovirta P; Ranta T; Seppälä M
    Acta Endocrinol (Copenh); 1978 Apr; 87(4):682-6. PubMed ID: 580517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatment of hyperprolactinemia with a new ergot derivative, lergotrile mesylate.
    Sherman BM; Swanson JA; Chapler FK
    Fertil Steril; 1978 Mar; 29(3):291-5. PubMed ID: 565303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of acute parlodel load on the prolactin and STH content in patients with various neuroendocrine diseases].
    Mel'nichenko GA; Bol'shakova TD; Gitel' EP; Langner TK; Barkova MV
    Probl Endokrinol (Mosk); 1983; 29(1):19-23. PubMed ID: 6682222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of triiodothyronine treatment on prolactin secretion in patients with amenorrhea-galactorrhea.
    Aono T; Shioji T; Miyai K; Onishi T; Kurachi K
    J Clin Endocrinol Metab; 1977 Jan; 44(1):8-14. PubMed ID: 401825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of bromocriptine to induce ovulation in the galactorrhea-amenorrhea syndrome [].
    Hernández Ayup S; Muñoz M; González R; Galache P; Guitrón A; Pancardo RM; Forsbach G
    Rev Invest Clin; 1982; 34(2):121-3. PubMed ID: 7123023
    [No Abstract]   [Full Text] [Related]  

  • 35. Predicted ovulatory response to 2-brom-alpha-ergocryptine (CB-154) in amenorrhea-galactorrhea syndromes.
    Shewchuk AB; Corenblum B; Pairaudeau N; Ezrin C; Adamson GD
    Am J Obstet Gynecol; 1980 Mar; 136(5):652-8. PubMed ID: 7188835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Results of the clinical use of Parlodel in the galactorrhea-amenorrhea syndrome and in acromegaly].
    Starkova NT; Mel'nichenko GA; Pronin VS
    Sov Med; 1978 Jun; (6):88-91. PubMed ID: 354025
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of bromocriptine on patients with hyperprolactinemia and amenorrhea.
    Meduri M; Deodato M; Bramanti P; Volpe A; Grasso A; Di Perri R
    Acta Neurol (Napoli); 1980 Feb; 2(1):15-22. PubMed ID: 7190350
    [No Abstract]   [Full Text] [Related]  

  • 38. Editorial: Galactorrhea-amenorrhea, brom-ergocryptine, and the dopamine receptor.
    Boyd AE; Reighlin S
    N Engl J Med; 1975 Aug; 293(9):451-2. PubMed ID: 1171365
    [No Abstract]   [Full Text] [Related]  

  • 39. [Successful treatment of galactorrhea, anemorrhea and infertility with a new ergot alkaloid (2-Br-alpha-ergocryptine)].
    Schellekens LA; Roland R; Lequin RM
    Ned Tijdschr Geneeskd; 1975 Apr; 119(14):541-7. PubMed ID: 1170514
    [No Abstract]   [Full Text] [Related]  

  • 40. Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.
    Lamberts SW; Seldenrath HJ; Kwa HG; Birkenhäger JC
    J Clin Endocrinol Metab; 1977 Jan; 44(1):180-4. PubMed ID: 576229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.